DOCK2 regulates cell proliferation through Rac and ERK activation in B cell lymphoma

Lei Wang, Hiroshi Nishihara, Taichi Kimura, Yasutaka Kato, Mishie Tanino, Mitsufumi Nishio, Masato Obara, Tomoyuki Endo, Takao Koike, Shinya Tanaka

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

DOCK2; a member of the CDM protein family, regulates cell motility and cytokine production through the activation of Rac in mammalian hematopoietic cells and plays a pivotal role in the modulation of the immune system. Here we demonstrated the alternative function of DOCK2 in hematopoietic tumor cells, especially in terms of its association with the tumor progression. Immunostaining for DOCK2 in 20 cases of human B cell lymphoma tissue specimens including diffuse large B cell lymphoma and follicular lymphoma revealed the prominent expression of DOCK2 in all of the lymphoma cells. DOCK2-knockdown (KD) of the B cell lymphoma cell lines, Ramos and Raji, using the lentiviral shRNA system presented decreased cell proliferation compared to the control cells. Furthermore, the tumor formation of DOCK2-KD Ramos cell in nude mice was significantly abrogated. Western blotting analysis and pull-down assay using GST-PAK-RBD kimeric protein suggested the presence of DOCK2-Rac-ERK pathway regulating the cell proliferation of these lymphoma cells. This is the first report to clarify the prominent role of DOCK2 in hematopoietic malignancy.

Original languageEnglish
Pages (from-to)111-115
Number of pages5
JournalBiochemical and Biophysical Research Communications
Volume395
Issue number1
DOIs
Publication statusPublished - 2010 Jan 1
Externally publishedYes

Fingerprint

Cell proliferation
B-Cell Lymphoma
Chemical activation
Cells
Cell Proliferation
Tumors
Lymphoma
Immune system
Neoplasms
Follicular Lymphoma
Lymphoma, Large B-Cell, Diffuse
MAP Kinase Signaling System
Small Interfering RNA
Hematologic Neoplasms
Assays
Proteins
Nude Mice
Cell Movement
Modulation
Association reactions

Keywords

  • B cell lymphoma
  • DOCK2
  • ERK
  • Hematopoietic malignancy
  • Rac

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

DOCK2 regulates cell proliferation through Rac and ERK activation in B cell lymphoma. / Wang, Lei; Nishihara, Hiroshi; Kimura, Taichi; Kato, Yasutaka; Tanino, Mishie; Nishio, Mitsufumi; Obara, Masato; Endo, Tomoyuki; Koike, Takao; Tanaka, Shinya.

In: Biochemical and Biophysical Research Communications, Vol. 395, No. 1, 01.01.2010, p. 111-115.

Research output: Contribution to journalArticle

Wang, L, Nishihara, H, Kimura, T, Kato, Y, Tanino, M, Nishio, M, Obara, M, Endo, T, Koike, T & Tanaka, S 2010, 'DOCK2 regulates cell proliferation through Rac and ERK activation in B cell lymphoma', Biochemical and Biophysical Research Communications, vol. 395, no. 1, pp. 111-115. https://doi.org/10.1016/j.bbrc.2010.03.148
Wang, Lei ; Nishihara, Hiroshi ; Kimura, Taichi ; Kato, Yasutaka ; Tanino, Mishie ; Nishio, Mitsufumi ; Obara, Masato ; Endo, Tomoyuki ; Koike, Takao ; Tanaka, Shinya. / DOCK2 regulates cell proliferation through Rac and ERK activation in B cell lymphoma. In: Biochemical and Biophysical Research Communications. 2010 ; Vol. 395, No. 1. pp. 111-115.
@article{f891fa96097143828ebec36a71881f9a,
title = "DOCK2 regulates cell proliferation through Rac and ERK activation in B cell lymphoma",
abstract = "DOCK2; a member of the CDM protein family, regulates cell motility and cytokine production through the activation of Rac in mammalian hematopoietic cells and plays a pivotal role in the modulation of the immune system. Here we demonstrated the alternative function of DOCK2 in hematopoietic tumor cells, especially in terms of its association with the tumor progression. Immunostaining for DOCK2 in 20 cases of human B cell lymphoma tissue specimens including diffuse large B cell lymphoma and follicular lymphoma revealed the prominent expression of DOCK2 in all of the lymphoma cells. DOCK2-knockdown (KD) of the B cell lymphoma cell lines, Ramos and Raji, using the lentiviral shRNA system presented decreased cell proliferation compared to the control cells. Furthermore, the tumor formation of DOCK2-KD Ramos cell in nude mice was significantly abrogated. Western blotting analysis and pull-down assay using GST-PAK-RBD kimeric protein suggested the presence of DOCK2-Rac-ERK pathway regulating the cell proliferation of these lymphoma cells. This is the first report to clarify the prominent role of DOCK2 in hematopoietic malignancy.",
keywords = "B cell lymphoma, DOCK2, ERK, Hematopoietic malignancy, Rac",
author = "Lei Wang and Hiroshi Nishihara and Taichi Kimura and Yasutaka Kato and Mishie Tanino and Mitsufumi Nishio and Masato Obara and Tomoyuki Endo and Takao Koike and Shinya Tanaka",
year = "2010",
month = "1",
day = "1",
doi = "10.1016/j.bbrc.2010.03.148",
language = "English",
volume = "395",
pages = "111--115",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - DOCK2 regulates cell proliferation through Rac and ERK activation in B cell lymphoma

AU - Wang, Lei

AU - Nishihara, Hiroshi

AU - Kimura, Taichi

AU - Kato, Yasutaka

AU - Tanino, Mishie

AU - Nishio, Mitsufumi

AU - Obara, Masato

AU - Endo, Tomoyuki

AU - Koike, Takao

AU - Tanaka, Shinya

PY - 2010/1/1

Y1 - 2010/1/1

N2 - DOCK2; a member of the CDM protein family, regulates cell motility and cytokine production through the activation of Rac in mammalian hematopoietic cells and plays a pivotal role in the modulation of the immune system. Here we demonstrated the alternative function of DOCK2 in hematopoietic tumor cells, especially in terms of its association with the tumor progression. Immunostaining for DOCK2 in 20 cases of human B cell lymphoma tissue specimens including diffuse large B cell lymphoma and follicular lymphoma revealed the prominent expression of DOCK2 in all of the lymphoma cells. DOCK2-knockdown (KD) of the B cell lymphoma cell lines, Ramos and Raji, using the lentiviral shRNA system presented decreased cell proliferation compared to the control cells. Furthermore, the tumor formation of DOCK2-KD Ramos cell in nude mice was significantly abrogated. Western blotting analysis and pull-down assay using GST-PAK-RBD kimeric protein suggested the presence of DOCK2-Rac-ERK pathway regulating the cell proliferation of these lymphoma cells. This is the first report to clarify the prominent role of DOCK2 in hematopoietic malignancy.

AB - DOCK2; a member of the CDM protein family, regulates cell motility and cytokine production through the activation of Rac in mammalian hematopoietic cells and plays a pivotal role in the modulation of the immune system. Here we demonstrated the alternative function of DOCK2 in hematopoietic tumor cells, especially in terms of its association with the tumor progression. Immunostaining for DOCK2 in 20 cases of human B cell lymphoma tissue specimens including diffuse large B cell lymphoma and follicular lymphoma revealed the prominent expression of DOCK2 in all of the lymphoma cells. DOCK2-knockdown (KD) of the B cell lymphoma cell lines, Ramos and Raji, using the lentiviral shRNA system presented decreased cell proliferation compared to the control cells. Furthermore, the tumor formation of DOCK2-KD Ramos cell in nude mice was significantly abrogated. Western blotting analysis and pull-down assay using GST-PAK-RBD kimeric protein suggested the presence of DOCK2-Rac-ERK pathway regulating the cell proliferation of these lymphoma cells. This is the first report to clarify the prominent role of DOCK2 in hematopoietic malignancy.

KW - B cell lymphoma

KW - DOCK2

KW - ERK

KW - Hematopoietic malignancy

KW - Rac

UR - http://www.scopus.com/inward/record.url?scp=77951926592&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951926592&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2010.03.148

DO - 10.1016/j.bbrc.2010.03.148

M3 - Article

C2 - 20350533

AN - SCOPUS:77951926592

VL - 395

SP - 111

EP - 115

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 1

ER -